$GRBK
Green Brick Partners, Inc. Stock $grbk

$grbk Overview Financials Valuation SEC Filings Company Website

2018 Q4 Form 10-Q Financial Statement

#000137367018000035 Filed on November 05, 2018

Income Statement

Concept	2018 Q4	2018 Q3	2017 Q4
Revenue	$185.1M	$152.1M	$137.4M
YoY Change	34.71%	32.98%	14.71%
Cost Of Revenue	$128.6M	$115.4M	$110.8M
YoY Change	16.06%	30.68%	22.3%
Gross Profit	$36.99M	$36.67M	$29.00M
YoY Change	27.56%	43.76%	-0.7%
Gross Profit Margin	19.98%	24.12%	21.1%
Selling, General & Admin	$39.90M	$19.64M	$10.30M
YoY Change	287.38%	106.33%	-1.9%
% of Gross Profit	107.87%	53.57%	35.52%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$1.140M	$760.0K	$90.00K
YoY Change	1166.67%	985.71%	0.0%
% of Gross Profit	3.08%	2.07%	0.31%
Operating Expenses	$41.60M	$19.64M	$10.30M
YoY Change	303.88%	106.33%	-0.96%
Operating Profit	-$4.612M	$16.68M	$18.70M
YoY Change	-124.67%	4.97%	-0.55%
Interest Expense	$700.0K	$2.700M	$1.800M
YoY Change	-61.11%
% of Operating Profit		16.19%	9.63%
Other Income/Expense, Net	-$200.0K	$363.0K	$100.0K
YoY Change	-300.0%	-16.55%	-75.0%
Pretax Income	$20.70M	$20.11M	$21.00M
YoY Change	-1.43%	16.27%	9.95%
Income Tax	$3.800M	$4.734M	$6.400M
% Of Pretax Income	18.36%	23.54%	30.48%
Net Earnings	$13.35M	$12.20M	-$8.195M
YoY Change	-262.95%	31.45%	-206.76%
Net Earnings / Revenue	7.21%	8.02%	-5.96%
Basic Earnings Per Share	$0.26	$0.24	-$0.16
Diluted Earnings Per Share	$0.26	$0.24	-$0.16
COMMON SHARES
Basic Shares Outstanding	50.72M shares	50.69M shares	50.58M shares
Diluted Shares Outstanding		50.78M shares

Balance Sheet

Concept	2018 Q4	2018 Q3	2017 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$38.30M	$33.10M	$36.70M
YoY Change	4.36%	59.9%	4.26%
Cash & Equivalents	$41.76M	$45.01M	$40.29M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory	$669.0M	$648.2M	$496.1M
Prepaid Expenses
Receivables	$4.800M	$4.100M	$1.600M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$712.1M	$685.4M	$534.4M
YoY Change	33.25%	36.83%	19.31%
LONG-TERM ASSETS
Property, Plant & Equipment	$4.690M	$4.201M	$804.0K
YoY Change	483.33%	516.89%	-9.87%
Goodwill	$680.0K	$680.0K	$0.00
YoY Change
Intangibles	$856.0K	$1.041M	$0.00
YoY Change
Long-Term Investments	$20.27M	$20.81M	$16.88M
YoY Change	20.09%	31.93%
Other Assets	$19.90M	$32.00M	$34.80M
YoY Change	-42.82%	-46.84%	-51.67%
Total Long-Term Assets	$71.93M	$85.62M	$76.60M
YoY Change	-6.11%	-18.93%	-17.71%
TOTAL ASSETS
Total Short-Term Assets	$712.1M	$685.4M	$534.4M
Total Long-Term Assets	$71.93M	$85.62M	$76.60M
Total Assets	$784.0M	$771.0M	$611.0M
YoY Change	28.32%	27.12%	12.94%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$26.10M	$35.00M	$22.40M
YoY Change	16.52%	116.05%	48.34%
Accrued Expenses	$29.20M	$23.60M	$18.50M
YoY Change	57.84%	42.17%	29.37%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$87.30M	$92.40M	$62.30M
YoY Change	40.13%	66.19%	43.22%
LONG-TERM LIABILITIES
Long-Term Debt	$208.9M	$207.9M	$115.7M
YoY Change	80.55%	97.62%	34.69%
Other Long-Term Liabilities	$2.200M	$500.0K	$0.00
YoY Change		-93.33%	-100.0%
Total Long-Term Liabilities	$211.1M	$208.4M	$115.7M
YoY Change	82.45%	84.92%	20.52%
TOTAL LIABILITIES
Total Short-Term Liabilities	$87.30M	$92.40M	$62.30M
Total Long-Term Liabilities	$211.1M	$208.4M	$115.7M
Total Liabilities	$289.9M	$293.0M	$178.0M
YoY Change	62.88%	74.12%	27.57%
SHAREHOLDERS EQUITY
Retained Earnings	$177.5M	$164.2M	$125.9M
YoY Change	41.0%	22.43%	13.49%
Common Stock	$291.8M	$291.5M	$290.4M
YoY Change	0.47%	0.48%	6.14%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$981.0K	$0.00	$0.00
YoY Change
Treasury Stock Shares
Shareholders Equity	$468.4M	$455.7M	$416.3M
YoY Change
Total Liabilities & Shareholders Equity	$784.0M	$771.0M	$611.0M
YoY Change	28.32%	27.12%	12.94%

Cashflow Statement

Concept	2018 Q4	2018 Q3	2017 Q4
OPERATING ACTIVITIES
Net Income	$13.35M	$12.20M	-$8.195M
YoY Change	-262.95%	31.45%	-206.76%
Depreciation, Depletion And Amortization	$1.140M	$760.0K	$90.00K
YoY Change	1166.67%	985.71%	0.0%
Cash From Operating Activities	-$1.150M	-$26.03M	$5.160M
YoY Change	-122.29%	-2.98%	-556.64%
INVESTING ACTIVITIES
Capital Expenditures	-$1.440M	-$590.0K	-$120.0K
YoY Change	1100.0%	1866.67%	0.0%
Acquisitions
YoY Change
Other Investing Activities	$0.00	-$1.520M	-$50.00K
YoY Change	-100.0%	533.33%
Cash From Investing Activities	-$1.450M	-$2.100M	-$170.0K
YoY Change	752.94%	677.78%	41.67%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-660.0K	31.94M	10.21M
YoY Change	-106.46%	56.42%	-264.41%
NET CHANGE
Cash From Operating Activities	-1.150M	-26.03M	5.160M
Cash From Investing Activities	-1.450M	-2.100M	-170.0K
Cash From Financing Activities	-660.0K	31.94M	10.21M
Net Change In Cash	-3.260M	3.810M	15.20M
YoY Change	-121.45%	-157.04%	-303.75%
FREE CASH FLOW
Cash From Operating Activities	-$1.150M	-$26.03M	$5.160M
Capital Expenditures	-$1.440M	-$590.0K	-$120.0K
Free Cash Flow	$290.0K	-$25.44M	$5.280M
YoY Change	-94.51%	-5.07%	-622.77%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2018Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	50719884	shares
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
	dei	Entity Registrant Name EntityRegistrantName	Green Brick Partners, Inc.
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2018
	dei	Document Period End Date DocumentPeriodEndDate	2018-09-30
	dei	Document Type DocumentType	10-Q
	dei	Entity Central Index Key EntityCentralIndexKey	0001373670
	dei	Entity Small Business EntitySmallBusiness	false
	grbk	Amortizationof Deferred Stock Compensation Amount AmortizationofDeferredStockCompensationAmount	301000	USD
	grbk	Contractwith Customer Primary Revenue Sources ContractwithCustomerPrimaryRevenueSources	2
CY2018Q3	grbk	Equity Method Investment Board Seats EquityMethodInvestmentBoardSeats	3
CY2017Q4	grbk	Equity Method Investment Summarized Financial Information Accounts Payable EquityMethodInvestmentSummarizedFinancialInformationAccountsPayable	5060000	USD
CY2018Q3	grbk	Equity Method Investment Summarized Financial Information Accounts Payable EquityMethodInvestmentSummarizedFinancialInformationAccountsPayable	4464000	USD
CY2017Q4	grbk	Equity Method Investment Summarized Financial Information Accounts Receivable EquityMethodInvestmentSummarizedFinancialInformationAccountsReceivable	1494000	USD
CY2018Q3	grbk	Equity Method Investment Summarized Financial Information Accounts Receivable EquityMethodInvestmentSummarizedFinancialInformationAccountsReceivable	400000	USD
CY2017Q4	grbk	Equity Method Investment Summarized Financial Information Accrued Expensesand Other Liabilities EquityMethodInvestmentSummarizedFinancialInformationAccruedExpensesandOtherLiabilities	2857000	USD
CY2018Q3	grbk	Equity Method Investment Summarized Financial Information Accrued Expensesand Other Liabilities EquityMethodInvestmentSummarizedFinancialInformationAccruedExpensesandOtherLiabilities	5373000	USD
CY2018Q3	grbk	Equity Method Investment Summarized Financial Information Inventory EquityMethodInvestmentSummarizedFinancialInformationInventory	50731000	USD
CY2017Q4	grbk	Equity Method Investment Summarized Financial Information Noncompete Intangible Asset EquityMethodInvestmentSummarizedFinancialInformationNoncompeteIntangibleAsset	202000	USD
CY2017Q4	grbk	Equity Method Investment Summarized Financial Information Cash EquityMethodInvestmentSummarizedFinancialInformationCash	3981000	USD
CY2018Q3	grbk	Equity Method Investment Summarized Financial Information Cash EquityMethodInvestmentSummarizedFinancialInformationCash	15825000	USD
CY2017Q4	grbk	Equity Method Investment Summarized Financial Information Goodwill EquityMethodInvestmentSummarizedFinancialInformationGoodwill	4615000	USD
CY2018Q3	grbk	Equity Method Investment Summarized Financial Information Goodwill EquityMethodInvestmentSummarizedFinancialInformationGoodwill	4615000	USD
CY2017Q4	grbk	Equity Method Investment Summarized Financial Information Inventory EquityMethodInvestmentSummarizedFinancialInformationInventory	57841000	USD
CY2018Q3	grbk	Equity Method Investment Summarized Financial Information Noncompete Intangible Asset EquityMethodInvestmentSummarizedFinancialInformationNoncompeteIntangibleAsset	159000	USD
CY2017Q4	grbk	Equity Method Investment Summarized Financial Information Notes Payable EquityMethodInvestmentSummarizedFinancialInformationNotesPayable	36923000	USD
CY2018Q3	grbk	Equity Method Investment Summarized Financial Information Notes Payable EquityMethodInvestmentSummarizedFinancialInformationNotesPayable	34209000	USD
CY2017Q4	grbk	Equity Method Investment Summarized Financial Information Other Assets EquityMethodInvestmentSummarizedFinancialInformationOtherAssets	2248000	USD
CY2018Q3	grbk	Equity Method Investment Summarized Financial Information Other Assets EquityMethodInvestmentSummarizedFinancialInformationOtherAssets	2652000	USD
CY2017Q4	grbk	Equity Method Investments Summarized Financial Information Bonds Receivable EquityMethodInvestmentsSummarizedFinancialInformationBondsReceivable	2850000	USD
CY2018Q3	grbk	Equity Method Investments Summarized Financial Information Bonds Receivable EquityMethodInvestmentsSummarizedFinancialInformationBondsReceivable	5864000	USD
	grbk	Increase Decrease In Inventories Not Owned IncreaseDecreaseInInventoriesNotOwned	2271000	USD
	grbk	Increase Decrease In Inventories Not Owned IncreaseDecreaseInInventoriesNotOwned	0	USD
CY2017Q4	grbk	Inventory Finished Homesand Land Heldfor Sale InventoryFinishedHomesandLandHeldforSale	106043000	USD
CY2018Q3	grbk	Inventory Finished Homesand Land Heldfor Sale InventoryFinishedHomesandLandHeldforSale	165107000	USD
CY2017Q4	grbk	Inventory Homesunder Constructionand Landunder Development InventoryHomesunderConstructionandLandunderDevelopment	386181000	USD
CY2018Q3	grbk	Inventory Homesunder Constructionand Landunder Development InventoryHomesunderConstructionandLandunderDevelopment	480419000	USD
CY2018Q3	grbk	Landand Lotsunder Purchase Options Expected Purchase Payments Remainderof Fiscal Year LandandLotsunderPurchaseOptionsExpectedPurchasePaymentsRemainderofFiscalYear	61746000	USD
CY2018Q3	grbk	Landand Lotsunder Purchase Options Expected Purchase Payments Total LandandLotsunderPurchaseOptionsExpectedPurchasePaymentsTotal	237870000	USD
CY2018Q3	grbk	Landand Lotsunder Purchase Options Expected Purchase Payments Year Five LandandLotsunderPurchaseOptionsExpectedPurchasePaymentsYearFive	1680000	USD
CY2018Q3	grbk	Landand Lotsunder Purchase Options Expected Purchase Payments Year Four LandandLotsunderPurchaseOptionsExpectedPurchasePaymentsYearFour	12244000	USD
CY2018Q3	grbk	Landand Lotsunder Purchase Options Expected Purchase Payments Year Three LandandLotsunderPurchaseOptionsExpectedPurchasePaymentsYearThree	27650000	USD
CY2018Q3	grbk	Landand Lotsunder Purchase Options Expected Purchase Payments Year Two LandandLotsunderPurchaseOptionsExpectedPurchasePaymentsYearTwo	134550000	USD
CY2017Q4	grbk	Lotsunder Purchase Options Number LotsunderPurchaseOptionsNumber	1724	lot
CY2018Q3	grbk	Lotsunder Purchase Options Number LotsunderPurchaseOptionsNumber	2672	lot
	grbk	Noncash Or Part Noncash Equity Investment Noncash Financial Or Equity Instrument Consideration Equity Issued Value NoncashOrPartNoncashEquityInvestmentNoncashFinancialOrEquityInstrumentConsiderationEquityIssuedValue	14623000	USD
	grbk	Noncash Or Part Noncash Equity Investment Noncash Financial Or Equity Instrument Consideration Equity Issued Value NoncashOrPartNoncashEquityInvestmentNoncashFinancialOrEquityInstrumentConsiderationEquityIssuedValue	0	USD
CY2018Q3	grbk	Operating Leases Future Minimum Payments Duein Five Yearsand Thereafter OperatingLeasesFutureMinimumPaymentsDueinFiveYearsandThereafter	443000	USD
	grbk	Stockholders Equity Including Portion Attributableto Noncontrolling Interest Distributions StockholdersEquityIncludingPortionAttributabletoNoncontrollingInterestDistributions	10746000	USD
CY2017Q4	us-gaap	Accounts Payable Current And Noncurrent AccountsPayableCurrentAndNoncurrent	22354000	USD
CY2018Q3	us-gaap	Accounts Payable Current And Noncurrent AccountsPayableCurrentAndNoncurrent	34998000	USD
CY2017Q4	us-gaap	Accounts Receivable Net AccountsReceivableNet	1605000	USD
CY2018Q3	us-gaap	Accounts Receivable Net AccountsReceivableNet	4059000	USD
CY2017Q4	us-gaap	Accrued Liabilities Current And Noncurrent AccruedLiabilitiesCurrentAndNoncurrent	18465000	USD
CY2018Q3	us-gaap	Accrued Liabilities Current And Noncurrent AccruedLiabilitiesCurrentAndNoncurrent	23645000	USD
CY2017Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	289938000	USD
CY2018Q3	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	291007000	USD
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	215000	USD
CY2017Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	200000	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	2242000	USD
CY2018Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	200000	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1597000	USD
CY2017Q3	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	0	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	0	shares
CY2018Q3	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	3000	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	7000	shares
CY2017Q4	us-gaap	Assets Assets	611003000	USD
CY2018Q3	us-gaap	Assets Assets	771016000	USD
	us-gaap	Assets Fair Value Adjustment AssetsFairValueAdjustment	0	USD
	us-gaap	Assets Fair Value Adjustment AssetsFairValueAdjustment	-100000	USD
CY2017Q4	us-gaap	Business Combination Contingent Consideration Liability BusinessCombinationContingentConsiderationLiability	0	USD
CY2018Q3	us-gaap	Business Combination Contingent Consideration Liability BusinessCombinationContingentConsiderationLiability	514000	USD
CY2016Q4	us-gaap	Cash Cash	35157000	USD
CY2017Q3	us-gaap	Cash Cash	20720000	USD
CY2017Q4	us-gaap	Cash Cash	36684000	USD
CY2018Q3	us-gaap	Cash Cash	33116000	USD
CY2016Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	39602000	USD
CY2017Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	25088000	USD
CY2017Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	40289000	USD
CY2018Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	45014000	USD
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-14514000	USD
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	4725000	USD
CY2017Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2018Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2017Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2018Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2017Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2018Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2017Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	50598901	shares
CY2018Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	50719884	shares
CY2017Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	50598901	shares
CY2018Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	50719884	shares
CY2017Q4	us-gaap	Common Stock Value CommonStockValue	506000	USD
CY2018Q3	us-gaap	Common Stock Value CommonStockValue	507000	USD
CY2017Q3	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	4556000	USD
	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	7945000	USD
CY2018Q3	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	6487000	USD
	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	13747000	USD
CY2017Q3	us-gaap	Contract With Customer Performance Obligation Satisfied In Previous Period ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod	0	USD
	us-gaap	Contract With Customer Performance Obligation Satisfied In Previous Period ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod	0	USD
CY2018Q3	us-gaap	Contract With Customer Performance Obligation Satisfied In Previous Period ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod	0	USD
	us-gaap	Contract With Customer Performance Obligation Satisfied In Previous Period ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod	0	USD
CY2017Q3	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	88296000	USD
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	248372000	USD
CY2018Q3	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	119334000	USD
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	340861000	USD
CY2016Q4	us-gaap	Customer Advances And Deposits CustomerAdvancesAndDeposits	14088000	USD
CY2017Q3	us-gaap	Customer Advances And Deposits CustomerAdvancesAndDeposits	22756000	USD
CY2017Q4	us-gaap	Customer Advances And Deposits CustomerAdvancesAndDeposits	21447000	USD
CY2018Q3	us-gaap	Customer Advances And Deposits CustomerAdvancesAndDeposits	33814000	USD
CY2017Q4	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	1227000	USD
CY2018Q3	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	1035000	USD
CY2017Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	31211000	USD
CY2018Q3	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	20091000	USD
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	11771000	USD
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	11120000	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	238000	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1804000	USD
CY2017Q4	us-gaap	Earnest Money Deposits EarnestMoneyDeposits	18393000	USD
CY2018Q3	us-gaap	Earnest Money Deposits EarnestMoneyDeposits	17890000	USD
CY2017Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.19
CY2017Q4	us-gaap	Equity Method Investment Summarized Financial Information Liabilities And Equity EquityMethodInvestmentSummarizedFinancialInformationLiabilitiesAndEquity	73231000	USD
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.47
CY2018Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.24
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.76
CY2017Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.19
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.47
CY2018Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.24
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.75
CY2017Q3	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.310
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.315
CY2018Q3	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.235
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.219
	us-gaap	Equity Method Investment Dividends Or Distributions EquityMethodInvestmentDividendsOrDistributions	259000	USD
	us-gaap	Equity Method Investment Dividends Or Distributions EquityMethodInvestmentDividendsOrDistributions	3361000	USD
CY2017Q4	us-gaap	Equity Method Investment Summarized Financial Information Assets EquityMethodInvestmentSummarizedFinancialInformationAssets	73231000	USD
CY2018Q3	us-gaap	Equity Method Investment Summarized Financial Information Assets EquityMethodInvestmentSummarizedFinancialInformationAssets	80246000	USD
CY2017Q3	us-gaap	Equity Method Investment Summarized Financial Information Cost Of Sales EquityMethodInvestmentSummarizedFinancialInformationCostOfSales	20015000	USD
	us-gaap	Equity Method Investment Summarized Financial Information Cost Of Sales EquityMethodInvestmentSummarizedFinancialInformationCostOfSales	20015000	USD
CY2018Q3	us-gaap	Equity Method Investment Summarized Financial Information Cost Of Sales EquityMethodInvestmentSummarizedFinancialInformationCostOfSales	38308000	USD
	us-gaap	Equity Method Investment Summarized Financial Information Cost Of Sales EquityMethodInvestmentSummarizedFinancialInformationCostOfSales	107328000	USD
CY2017Q4	us-gaap	Equity Method Investment Summarized Financial Information Equity EquityMethodInvestmentSummarizedFinancialInformationEquity	28391000	USD
CY2018Q3	us-gaap	Equity Method Investment Summarized Financial Information Equity EquityMethodInvestmentSummarizedFinancialInformationEquity	36200000	USD
CY2017Q4	us-gaap	Equity Method Investment Summarized Financial Information Equity Or Capital EquityMethodInvestmentSummarizedFinancialInformationEquityOrCapital	11799000	USD
CY2018Q3	us-gaap	Equity Method Investment Summarized Financial Information Equity Or Capital EquityMethodInvestmentSummarizedFinancialInformationEquityOrCapital	15724000	USD
CY2017Q4	us-gaap	Equity Method Investment Summarized Financial Information Liabilities EquityMethodInvestmentSummarizedFinancialInformationLiabilities	44840000	USD
CY2018Q3	us-gaap	Equity Method Investment Summarized Financial Information Liabilities EquityMethodInvestmentSummarizedFinancialInformationLiabilities	44046000	USD
CY2018Q3	us-gaap	Equity Method Investment Summarized Financial Information Liabilities And Equity EquityMethodInvestmentSummarizedFinancialInformationLiabilitiesAndEquity	80246000	USD
CY2017Q4	us-gaap	Equity Method Investment Summarized Financial Information Minority Interest EquityMethodInvestmentSummarizedFinancialInformationMinorityInterest	16592000	USD
CY2018Q3	us-gaap	Equity Method Investment Summarized Financial Information Minority Interest EquityMethodInvestmentSummarizedFinancialInformationMinorityInterest	20476000	USD
CY2017Q3	us-gaap	Equity Method Investment Summarized Financial Information Net Income Loss EquityMethodInvestmentSummarizedFinancialInformationNetIncomeLoss	1940000	USD
	us-gaap	Equity Method Investment Summarized Financial Information Net Income Loss EquityMethodInvestmentSummarizedFinancialInformationNetIncomeLoss	1940000	USD
CY2018Q3	us-gaap	Equity Method Investment Summarized Financial Information Net Income Loss EquityMethodInvestmentSummarizedFinancialInformationNetIncomeLoss	5450000	USD
	us-gaap	Equity Method Investment Summarized Financial Information Net Income Loss EquityMethodInvestmentSummarizedFinancialInformationNetIncomeLoss	13382000	USD
CY2017Q3	us-gaap	Equity Method Investment Summarized Financial Information Revenue EquityMethodInvestmentSummarizedFinancialInformationRevenue	21955000	USD
	us-gaap	Equity Method Investment Summarized Financial Information Revenue EquityMethodInvestmentSummarizedFinancialInformationRevenue	21955000	USD
CY2018Q3	us-gaap	Equity Method Investment Summarized Financial Information Revenue EquityMethodInvestmentSummarizedFinancialInformationRevenue	43758000	USD
	us-gaap	Equity Method Investment Summarized Financial Information Revenue EquityMethodInvestmentSummarizedFinancialInformationRevenue	120710000	USD
CY2017Q4	us-gaap	Equity Method Investments EquityMethodInvestments	16878000	USD
CY2018Q3	us-gaap	Equity Method Investments EquityMethodInvestments	20806000	USD
CY2017Q4	us-gaap	Goodwill Goodwill	0	USD
CY2018Q3	us-gaap	Goodwill Goodwill	680000	USD
CY2017Q3	us-gaap	Gross Profit GrossProfit	25410000	USD
	us-gaap	Gross Profit GrossProfit	69622000	USD
CY2018Q3	us-gaap	Gross Profit GrossProfit	30658000	USD
	us-gaap	Gross Profit GrossProfit	92406000	USD
CY2017Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	17293000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	43220000	USD
CY2018Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	20107000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	60948000	USD
CY2017Q3	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	968000	USD
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	968000	USD
CY2018Q3	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	2719000	USD
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	6534000	USD
CY2017Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	5364000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	13635000	USD
CY2018Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	4734000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	13341000	USD
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	2872000	USD
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	3400000	USD
	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	910000	USD
	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	8424000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-640000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	2245000	USD
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	2463000	USD
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	3914000	USD
	us-gaap	Increase Decrease In Customer Deposits IncreaseDecreaseInCustomerDeposits	8668000	USD
	us-gaap	Increase Decrease In Customer Deposits IncreaseDecreaseInCustomerDeposits	3293000	USD
	us-gaap	Increase Decrease In Earnest Money Deposits Outstanding IncreaseDecreaseInEarnestMoneyDepositsOutstanding	6905000	USD
	us-gaap	Increase Decrease In Earnest Money Deposits Outstanding IncreaseDecreaseInEarnestMoneyDepositsOutstanding	-1021000	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	70605000	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	108634000	USD
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	1460000	USD
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	3053000	USD
CY2017Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	0	USD
CY2018Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	1041000	USD
	us-gaap	Interest Paid Net InterestPaidNet	0	USD
	us-gaap	Interest Paid Net InterestPaidNet	0	USD
CY2017Q4	us-gaap	Inventory Land Held For Sale InventoryLandHeldForSale	3830000	USD
CY2018Q3	us-gaap	Inventory Land Held For Sale InventoryLandHeldForSale	2715000	USD
CY2017Q4	us-gaap	Inventory Operative Builders InventoryOperativeBuilders	496054000	USD
CY2018Q3	us-gaap	Inventory Operative Builders InventoryOperativeBuilders	648241000	USD
CY2017Q4	us-gaap	Inventory Real Estate InventoryRealEstate	496054000	USD
CY2018Q3	us-gaap	Inventory Real Estate InventoryRealEstate	648241000	USD
CY2017Q4	us-gaap	Letters Of Credit Outstanding Amount LettersOfCreditOutstandingAmount	200000	USD
CY2018Q3	us-gaap	Letters Of Credit Outstanding Amount LettersOfCreditOutstandingAmount	200000	USD
CY2017Q4	us-gaap	Liabilities Liabilities	177965000	USD
CY2018Q3	us-gaap	Liabilities Liabilities	292981000	USD
CY2017Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	611003000	USD
CY2018Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	771016000	USD
	us-gaap	Liabilities Fair Value Adjustment LiabilitiesFairValueAdjustment	0	USD
	us-gaap	Liabilities Fair Value Adjustment LiabilitiesFairValueAdjustment	100000	USD
CY2017Q4	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	105773000	USD
CY2018Q3	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	198965000	USD
CY2017Q4	us-gaap	Long Term Debt LongTermDebt	105773000	USD
CY2018Q3	us-gaap	Long Term Debt LongTermDebt	198965000	USD
CY2017Q4	us-gaap	Minority Interest MinorityInterest	16691000	USD
CY2018Q3	us-gaap	Minority Interest MinorityInterest	14508000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	8916000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	72433000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-268000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-29383000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-23162000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-38325000	USD
CY2017Q3	us-gaap	Net Income Loss NetIncomeLoss	9280000	USD
	us-gaap	Net Income Loss NetIncomeLoss	23165000	USD
CY2018Q3	us-gaap	Net Income Loss NetIncomeLoss	12197000	USD
	us-gaap	Net Income Loss NetIncomeLoss	38269000	USD
CY2017Q3	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	2649000	USD
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	6420000	USD
CY2018Q3	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	3176000	USD
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	9338000	USD
CY2018Q2	us-gaap	Net Income Loss Attributable To Redeemable Noncontrolling Interest NetIncomeLossAttributableToRedeemableNoncontrollingInterest	775000	USD
	us-gaap	Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest	46832000	USD
CY2017Q4	us-gaap	Notes Payable NotesPayable	9926000	USD
CY2018Q3	us-gaap	Notes Payable NotesPayable	1045000	USD
CY2017Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	15890000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	40890000	USD
CY2018Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	16679000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	51647000	USD
CY2018Q3	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	4154000	USD
CY2018Q3	us-gaap	Operating Leases Future Minimum Payments Due Current OperatingLeasesFutureMinimumPaymentsDueCurrent	1023000	USD
CY2018Q3	us-gaap	Operating Leases Future Minimum Payments Due In Four Years OperatingLeasesFutureMinimumPaymentsDueInFourYears	582000	USD
CY2018Q3	us-gaap	Operating Leases Future Minimum Payments Due In Three Years OperatingLeasesFutureMinimumPaymentsDueInThreeYears	795000	USD
CY2018Q3	us-gaap	Operating Leases Future Minimum Payments Due In Two Years OperatingLeasesFutureMinimumPaymentsDueInTwoYears	1033000	USD
CY2018Q3	us-gaap	Operating Leases Future Minimum Payments Remainder Of Fiscal Year OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear	278000	USD
CY2017Q4	us-gaap	Other Assets OtherAssets	5769000	USD
CY2018Q3	us-gaap	Other Assets OtherAssets	8993000	USD
CY2017Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	435000	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	1362000	USD
CY2018Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	709000	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	2767000	USD
	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	452000	USD
	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	228000	USD
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	586000	USD
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	412000	USD
	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	0	USD
	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	26861000	USD
	us-gaap	Payments To Acquire Equity Method Investments PaymentsToAcquireEquityMethodInvestments	241000	USD
	us-gaap	Payments To Acquire Equity Method Investments PaymentsToAcquireEquityMethodInvestments	755000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	27000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1767000	USD
	us-gaap	Payments To Minority Shareholders PaymentsToMinorityShareholders	9740000	USD
	us-gaap	Payments To Minority Shareholders PaymentsToMinorityShareholders	10746000	USD
CY2017Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2018Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2017Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2018Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2017Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2018Q3	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2017Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2018Q3	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2017Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2018Q3	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	61500000	USD
	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	133000000	USD
	us-gaap	Proceeds From Minority Shareholders ProceedsFromMinorityShareholders	438000	USD
	us-gaap	Proceeds From Minority Shareholders ProceedsFromMinorityShareholders	0	USD
CY2017Q3	us-gaap	Profit Loss ProfitLoss	11929000	USD
	us-gaap	Profit Loss ProfitLoss	29585000	USD
CY2018Q3	us-gaap	Profit Loss ProfitLoss	15373000	USD
	us-gaap	Profit Loss ProfitLoss	47607000	USD
CY2017Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	804000	USD
CY2018Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	4201000	USD
CY2016Q4	us-gaap	Real Estate Inventory Capitalized Interest Costs RealEstateInventoryCapitalizedInterestCosts	9417000	USD
CY2017Q2	us-gaap	Real Estate Inventory Capitalized Interest Costs RealEstateInventoryCapitalizedInterestCosts	9425000	USD
CY2017Q3	us-gaap	Real Estate Inventory Capitalized Interest Costs RealEstateInventoryCapitalizedInterestCosts	9886000	USD
CY2017Q4	us-gaap	Real Estate Inventory Capitalized Interest Costs RealEstateInventoryCapitalizedInterestCosts	10474000	USD
CY2018Q2	us-gaap	Real Estate Inventory Capitalized Interest Costs RealEstateInventoryCapitalizedInterestCosts	12143000	USD
CY2018Q3	us-gaap	Real Estate Inventory Capitalized Interest Costs RealEstateInventoryCapitalizedInterestCosts	13508000	USD
CY2017Q3	us-gaap	Real Estate Inventory Capitalized Interest Costs Cost Of Sales1 RealEstateInventoryCapitalizedInterestCostsCostOfSales1	716000	USD
	us-gaap	Real Estate Inventory Capitalized Interest Costs Cost Of Sales1 RealEstateInventoryCapitalizedInterestCostsCostOfSales1	2486000	USD
CY2018Q3	us-gaap	Real Estate Inventory Capitalized Interest Costs Cost Of Sales1 RealEstateInventoryCapitalizedInterestCostsCostOfSales1	1114000	USD
	us-gaap	Real Estate Inventory Capitalized Interest Costs Cost Of Sales1 RealEstateInventoryCapitalizedInterestCostsCostOfSales1	3079000	USD
CY2017Q3	us-gaap	Real Estate Inventory Capitalized Interest Costs Incurred RealEstateInventoryCapitalizedInterestCostsIncurred	1177000	USD
	us-gaap	Real Estate Inventory Capitalized Interest Costs Incurred RealEstateInventoryCapitalizedInterestCostsIncurred	2955000	USD
CY2018Q3	us-gaap	Real Estate Inventory Capitalized Interest Costs Incurred RealEstateInventoryCapitalizedInterestCostsIncurred	2479000	USD
	us-gaap	Real Estate Inventory Capitalized Interest Costs Incurred RealEstateInventoryCapitalizedInterestCostsIncurred	6113000	USD
CY2017Q4	us-gaap	Redeemable Noncontrolling Interest Equity Carrying Amount RedeemableNoncontrollingInterestEquityCarryingAmount	0	USD
CY2018Q3	us-gaap	Redeemable Noncontrolling Interest Equity Carrying Amount RedeemableNoncontrollingInterestEquityCarryingAmount	7841000	USD
CY2018Q2	us-gaap	Redeemable Noncontrolling Interest Equity Carrying Amount RedeemableNoncontrollingInterestEquityCarryingAmount	6346000	USD
	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	41500000	USD
	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	40000000	USD
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	744000	USD
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	9181000	USD
CY2016Q4	us-gaap	Restricted Cash RestrictedCash	4445000	USD
CY2018Q3	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1 RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1	P1Y
CY2018Q3	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1 RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1	P1Y
CY2018Q3	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1 RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1	P1Y
CY2018Q3	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1 RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
CY2017Q3	us-gaap	Restricted Cash RestrictedCash	4368000	USD
CY2017Q4	us-gaap	Restricted Cash RestrictedCash	3605000	USD
CY2017Q3	us-gaap	Revenues Revenues	113706000	USD
	us-gaap	Revenues Revenues	317994000	USD
CY2018Q3	us-gaap	Revenues Revenues	149992000	USD
	us-gaap	Revenues Revenues	433267000	USD
CY2018Q3	us-gaap	Restricted Cash RestrictedCash	11898000	USD
CY2017Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	125903000	USD
CY2018Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	164172000	USD
CY2018Q3	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	10631000	USD
CY2018Q3	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	51949000	USD
CY2018Q3	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	37051000	USD
CY2018Q3	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	16227000	USD
CY2018Q3	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	3730000	USD
CY2018Q3	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	119588000	USD
CY2018Q3	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1 RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1	P3M
CY2017Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	9520000	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	28732000	USD
CY2018Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	13979000	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	40759000	USD
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod	0	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue	0.00
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod	140000	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	10.45
CY2017Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	38000	shares
CY2018Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	34000	shares
CY2017Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	10.25
CY2018Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	12.00
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod	144000	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue	10.03
CY2018Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	300000	shares
CY2018Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	7.49
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	0	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod	0	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod	0	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	0.00
CY2018Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	1305000	USD
CY2017Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	500000	shares
CY2018Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	500000	shares
CY2017Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	7.49
CY2018Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	7.49
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0.00
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0.00
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	0.00
CY2018Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	783000	USD
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P6Y0M27D
CY2017Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares	200000	shares
CY2018Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares	200000	shares
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares	0	shares
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue	0.00
CY2017Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	2.88
CY2018Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	2.88
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P6Y0M27D
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares	0	shares
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue	0.00
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	0	shares
	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	0	USD
	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	669000	USD
CY2018Q3	us-gaap	Stock Repurchase Program Authorized Amount1 StockRepurchaseProgramAuthorizedAmount1	30000000	USD
CY2017Q4	us-gaap	Stockholders Equity StockholdersEquity	416347000	USD
CY2018Q3	us-gaap	Stockholders Equity StockholdersEquity	455686000	USD
CY2017Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	433038000	USD
CY2018Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	470194000	USD
CY2018Q2	us-gaap	Temporary Equity Accretion To Redemption Value TemporaryEquityAccretionToRedemptionValue	115000	USD
	us-gaap	Temporary Equity Accretion To Redemption Value Adjustment TemporaryEquityAccretionToRedemptionValueAdjustment	115000	USD
CY2017Q4	us-gaap	Variable Interest Entity Consolidated Assets Not Pledged VariableInterestEntityConsolidatedAssetsNotPledged	56100000	USD
CY2018Q3	us-gaap	Variable Interest Entity Consolidated Assets Not Pledged VariableInterestEntityConsolidatedAssetsNotPledged	65500000	USD
CY2017Q3	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	84000	shares
	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	73000	shares
CY2018Q3	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	92000	shares
	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	118000	shares
CY2017Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	49892000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	49347000	shares
CY2018Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	50778000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	50760000	shares
CY2017Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	49808000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	49274000	shares
CY2018Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	50686000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	50642000	shares
	us-gaap	Basis Of Accounting BasisOfAccounting	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with United States generally accepted accounting principles (“GAAP”) as set forth in the Financial Accounting Standards Board’s (“FASB”) Accounting Standards Codification (“ASC”) and applicable regulations of the Securities and Exchange Commission (“SEC”), but do not include all of the information and footnotes required for complete financial statements. In the opinion of management, the accompanying condensed consolidated financial statements for the periods presented reflect all adjustments, of a normal, recurring nature necessary to fairly state our financial position, results of operations and cash flows. These condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and accompanying notes included in the Company's Annual Report on Form 10-K for the year ended </font><font style="font-family:inherit;font-size:10pt;">December 31, 2017</font><font style="font-family:inherit;font-size:10pt;">. </font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Operating results for the three and </font><font style="font-family:inherit;font-size:10pt;">nine</font><font style="font-family:inherit;font-size:10pt;"> months ended </font><font style="font-family:inherit;font-size:10pt;">September 30, 2018</font><font style="font-family:inherit;font-size:10pt;"> are not necessarily indicative of the results that may be expected for the fiscal year ending </font><font style="font-family:inherit;font-size:10pt;">December 31, 2018</font><font style="font-family:inherit;font-size:10pt;"> or subsequent periods.</font></div></div>
	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;text-decoration:underline;">Reclassifications</font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Certain prior period amounts have been reclassified to conform to the current period presentation.</font></div></div>
	us-gaap	Use Of Estimates UseOfEstimates	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:8px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;text-decoration:underline;">Use of Estimates</font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The preparation of the condensed consolidated financial statements in conformity with GAAP requires the Company to make estimates and assumptions that affect the amounts reported in the condensed consolidated financial statements and accompanying notes, including the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements and the reported amounts of revenue and expenses during the reporting periods. Actual results could differ from those estimates.</font></div></div>

Files In Submission

Name	View Source	Status
0001373670-18-000035-index-headers.html	Edgar Link	pending
0001373670-18-000035-index.html	Edgar Link	pending
0001373670-18-000035.txt	Edgar Link	pending
0001373670-18-000035-xbrl.zip	Edgar Link	pending
a930201810-q.htm	Edgar Link	pending
exhibit101fifthamendmentto.htm	Edgar Link	pending
exhibit311certificationofc.htm	Edgar Link	pending
exhibit312certificationofc.htm	Edgar Link	pending
exhibit321certificationofc.htm	Edgar Link	pending
exhibit322certificationofc.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
grbk-20180930.xml	Edgar Link	completed
grbk-20180930.xsd	Edgar Link	pending
grbk-20180930_cal.xml	Edgar Link	unprocessable
grbk-20180930_def.xml	Edgar Link	unprocessable
grbk-20180930_lab.xml	Edgar Link	unprocessable
grbk-20180930_pre.xml	Edgar Link	unprocessable
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$GRBK
Green Brick Partners, Inc. Stock $grbk

2018 Q4 Form 10-Q Financial Statement

#000137367018000035 Filed on November 05, 2018

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$GRBK Green Brick Partners, Inc. Stock $grbk

2018 Q4 Form 10-Q Financial Statement

#000137367018000035 Filed on November 05, 2018

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$GRBK
Green Brick Partners, Inc. Stock $grbk